Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02765178 · ClinicalTrials.gov registry record
Apathy in Tourette Syndrome and Changes in Quality of Life
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 38
- Enrollment target
NCT02765178: Completed study, sponsored by University of Florida.
NCT02765178 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02765178 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
Tourette syndrome is a complex neuropsychological disorder with both motor and vocal tics associated with multiple psychological co-morbidities. Apathy has not been widely studied in patients with Tourette syndrome. Apathy can result in decrease in self-care and disease control. In this study investigators will compare the occurrence of apathy in the adolescent Tourette syndrome population (at the UF center for movement disorders and Neurorestoration) to an age and gender matched control population. Investigators will also assess the role of commonly used medications in the Tourette population (neuroleptics and selective serotonin receptor inhibitors) in the occurrence of apathy.
Primary Outcome
A 16-item questionnaire to evaluate level of motivation in children and adolescents completed by the primary caregiver.
Interventions
- OTHER Children's Motivation Scale
- OTHER Yale Global Tic Severity Scale (YGTSS)
- OTHER Studies Depression Scale for Children (CES-DC)
- OTHER Gilles de la Tourette Syndrome Quality Of Life scale
- OTHER Demographic Data
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2016-04 |
| Est. Completion | 2017-04 |
What the finished NCT02765178 record still lists
NCT02765178 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which Children's Motivation Scale is the first listed.
NCT02765178 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02765178 about?
NCT02765178 is a clinical study titled "Apathy in Tourette Syndrome and Changes in Quality of Life". Tourette syndrome is a complex neuropsychological disorder with both motor and vocal tics associated with multiple psychological co-morbidities. Apathy has not been widely studied in patients with Tourette syndrome. Apathy can result in decrease in self-care and disease control. In this study invest...
What is the current status of trial NCT02765178?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2016-04. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02765178?
The interventions under investigation include: Children's Motivation Scale (OTHER), Yale Global Tic Severity Scale (YGTSS) (OTHER), Studies Depression Scale for Children (CES-DC) (OTHER), Gilles de la Tourette Syndrome Quality Of Life scale (OTHER), Demographic Data (OTHER).
Who is sponsoring clinical trial NCT02765178?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia